NCT02650700View on ClinicalTrials.gov

Spleen Radiotherapy Decreases Severe CIT in Advanced NSCLC (SPLEENIR)

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

April 30, 2020

Study Completion Date

April 30, 2020

Conditions
Chemotherapy in Non-Small Cell Lung Cancer
Interventions
RADIATION

spleen radiotherapy

Radiation: spleen radiation In Experimental arm, combine spleen radiation with chemotherapy. In Chemotherapy alone arm, the subjects should also receive spleen radiation once there is a severe CIT (≧grade III) during chemotherapy after radomization.

All Listed Sponsors
lead

Xinqiao Hospital of Chongqing

OTHER

NCT02650700 - Spleen Radiotherapy Decreases Severe CIT in Advanced NSCLC (SPLEENIR) | Biotech Hunter | Biotech Hunter